Posts Tagged: "Forest Laboratories"

Pharma & Biotech News for September 2013

Mark Lemley’s Firm Files DJ Against Myriad in Northern California —– Promise Not to Infringe Insufficient in ANDA Litigation —– Licensing Deals Stall in Pharmaceutical Sector in First Half of 2013 —– Mylan Settles with FTC over Agila Acquisition from Strides —– Amgen and ShanghaiTech University Announce China R&D Center —– Forest Laboratories sues over SAVELLA® generics —– Teva Pharmaceutical scores patent cictory over Mylan on AZILECT® —– Patent Awarded to New Hepatitis C Treatment —– Orphan drug designation for treatment of Acute Radiation Syndrome —– Avanir settles ANDA litigation with Actavis over NUEDEXTA

Patent Litigation Settlement Roundup

On November 8, 2012, Mylan Inc. (Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. (NASDAQ: WETF) announced that Research Affiliates will withdraw its patent infringement lawsuit brought against WisdomTree and pay WisdomTree $700,000. On October 31, 2012, Acacia Research Corporation (Nasdaq:ACTG) announced that its subsidiaries settled patent litigation with Medtronic and Comcast Cable in unrelated cases.